Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection

Background Reports of hepatitis B virus (HBV) reactivation in solid tumors are very limited, and their frequencies and risk factors were previously unknown. Aim To evaluate the prevalence and risk factors of HBV reactivation in patients with solid tumors with resolved HBV infection. Methods All 1088...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asia-Pacific journal of clinical oncology 2019-02, Vol.15 (1), p.63-68
Hauptverfasser:	Kotake, Takeshi, Satake, Hironaga, Okita, Yoshihiro, Hatachi, Yukimasa, Hamada, Mamiko, Omiya, Masatomo, Yasui, Hisateru, Hashida, Toru, Kaihara, Satoshi, Inokuma, Tetsuro, Tsuji, Akihito
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antiviral Agents - therapeutic use Case-Control Studies de novo hepatitis Deoxyribonucleic acid Dexamethasone DNA Female HBs antibody Health risk assessment Hepatitis Hepatitis B Hepatitis B - drug therapy Hepatitis B - epidemiology Hepatitis B - virology Hepatitis B virus - drug effects Humans Infections Japan - epidemiology Male Middle Aged Neoplasms - drug therapy Neoplasms - virology Original Prevalence resolved HBV infection Retrospective Studies Risk Factors solid tumor Solid tumors steroid Tumors Virus Activation - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!